The Medical Device Market: Brazil

Publisher Name :
Date: 29-Jan-2014
No. of pages: 217

Overview

Brazil has the largest economy and medical device market in Latin America, but per capita medical expenditure is still very low. The highest expenditure is in the large cities, such as São Paulo or Rio de Janeiro, but producers are moving into regional markets outside the major state capitals. The medical device market in 2013 is valued at US$5,918.9mn, equal to US$29.6 per capita.

The public health system (SUS), created in 1988, provides healthcare services to around 75% of the population and the private sector 25%. However, the majority of inpatient services within the SUS are operated by private providers, with more than two-thirds of hospital facilities operated by the private sector. Further private investment in the health sector is being encouraged through a public-private partnership scheme launched in 2008, which is supported by the International Finance Corporation, the Brazilian Development Bank and the Inter-American Development Bank.

Brazil has the second largest private health insurance sector in the Americas, after the USA, covering around 25% of the population, 48mn people, in 2012. The expansion of the private health insurance sector in recent years has resulted in demand for better medical care and, in turn, further expenditure in medical equipment. The economic downturn has not affected hospital capital investments so severely. The public sector continues to be modernised and to upgrade obsolete equipment, therefore there are sizeable market opportunities if prices are competitive.

The government is extending healthcare service access through its Mais Saúde programme launched at the end of 2007, phase 2 of which is set to run until 2014. This programme has focused attention on developing the primary care network.

The government continues to invest in the expansion of the SUS. In 2013, BRL2.3bn (US$1.1bn) will be invested to support the development of primary health and emergency care services. A total of BRL$1.39bn (US$662mn) has also been invested in university hospitals since 2010 under the National University Hospital Restructuring programme (REHUF), which aims to improve access and quality of tertiary services provided to patients as well as the working and training conditions of medical students.

Medical device mports hold a relatively small share of the market, totalling US$2.8bn in 2012. They increased by 8.0% in 2012, but the CAGR 2007-2012 was much higher at 14.8%. Imports tend to be hightech medical equipment not produced locally. In 2012, over 75% of imports were supplied by Europe and the USA.

Brazilian medical device exports totalled US$524.6mn in 2012, a fall of 5.4% over 2011. The country has a well-established medical industry, comprising local and multinational companies. Domestic production, however, is geared towards the local market. Exports are small in comparison with total production and the country consistently runs a negative balance of trade in medical equipment and supplies.

The Medical Device Market: Brazil

Table of Contents

Espicom Industry View   7
Espicom Industry View      7
SWOT     9
Medical Device Market      9
Political     10
Economic    11
Business Environment     12
Industry Forecast     13
Medical Device Market Forecast    13
Past Performance 2008-2013    13
Future Performance 2013-2018    14
Table: Projected Medical Device Market, 2013-2018     15
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$mn)   16
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita)  20
Table: Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total)     23
Table: Detailed Medical Device Market By Product Area, 2009-2018 (US$mn, % Change)  26
Consumables Market Forecast    29
Table: Consumables Market, 2008-2018 (US$mn)  31
Table: Consumables Market, 2008-2018 (US$ Per Capita)    32
Table: Consumables Market, 2009-2018 (US$mn % Change)    33
Diagnostic Imaging Market Forecast     35
Electrodiagnostic Apparatus Sector   36
Radiation Apparatus Sector     37
Imaging Parts & Accessories Sector     38
Table: Diagnostic Imaging Market, 2008-2018 (US$mn)     38
Table: Diagnostic Imaging Market, 2008-2018 (US$ Per Capita)   39
Table: Diagnostic Imaging Market, 2009-2018 (US$mn % Change)     40
Dental Products Market Forecast   42
Table: Dental Products Market, 2008-2018 (US$mn)     44
Table: Dental Products Market, 2008-2018 (US$ Per Capita)  44
Table: Dental Products Market, 2009-2018 (US$mn % Change)     45
Orthopaedics & Prosthetics Market Forecast  47
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$mn)   48
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$ Per Capita)   49
Table: Orthopaedics & Prosthetics Market, 2009-2018 (US$mn % Change)      49
Patient Aids Market Forecast     51
Table: Patient Aids Market, 2008-2018 (US$mn)    52
Table: Patient Aids Market, 2008-2018 (US$ Per Capita)   53
Table: Patient Aids Market, 2009-2018 (US$mn % Change)   53
Other Medical Devices Market Forecast    55
Table: Other Medical Devices Market, 2008-2018 (US$mn)   56
Table: Other Medical Devices Market, 2008-2018 (US$ Per Capita)  57
Table: Other Medical Devices Market, 2009-2018 (US$mn % Change)      58
Annual Medical Device Imports     60
Table: Medical Device Imports By Product Area, 2008-2012 (US$000s)      64
Table: Medical Device Imports By Product Area, 2008-2012 (US$000s, % Change)  65
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s)     66
Table: Medical Device Imports By Product Area 2008-2012 (Local Currency 000s, % Change)   67
Table: Medical Device Imports By Product Area 2008-2012 (% Distribution)   68
Table: Leading Medical Device Suppliers By Product Area, 2012 (US$000s)   71
Table: Leading Medical Device Suppliers By Product Area, 2012 (% Distribution)     72
Table: Top 20 Medical Device Suppliers, 2012 (US$000s)    73
Table: Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s)  74
Table: Detailed Medical Device Import Trends By Product Area, 2012      77
Table: Detailed Leading Medical Device Suppliers By Product Area, 2012 (US$000s)  81
Monthly Medical Device Imports    85
Table: Monthly Medical Device Imports By Product Area, October 2010 - September 2013 (US$mn)      85
Annual Medical Device Exports     87
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s)      89
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change)  90
Table: Medical Device Exports By Product Area 2008-2012, (Local Currency 000s)     91
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change)      92
Table: Medical Device Exports By Product Area, 2008-2012 (% Distribution)      94
Table: Leading Medical Device Destinations By Product Area, 2012 (US$000s)      97
Table: Leading Medical Device Destinations By Product Area, 2012 (% Distribution)  98
Table: Top 20 Medical Device Destinations, 2012 (US$000s)  99
Table: Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s)  100
Table: Detailed Medical Device Export Trends By Product Area, 2012   103
Table: Detailed Leading Medical Device Destinations By Product Area, 2012 (US$000s)     107
Table: Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s)   110
Monthly Medical Device Exports     114
Table: Monthly Medical Device Exports By Product Area, October 2010 - September 2013 (US$mn)  114
Macroeconomic Forecasts  116
Table: Brazil - Economic Activity     122
Industry Risk Reward Ratings      123
Industry Risk Reward Ratings   123
Table: Espicom Analysis Of The Medical Device Market, 2013     123
Market Overview     125
Medical Device Market Overview     125
Overview     125
Table: Medical Device Market, Key Ratios, 2013  127
The Market In 2013     127
Table: Medical Device Market By Product Area, 2013   128
Healthcare Overview     131
Healthcare System      131
Main World Bank Health-Related Projects  132
Health Insurance   133
Health Expenditure     134
Medical Device Technology    134
Table: Medical Device Technology By Type, 2005-2012     135
Key Data     137
Table: Key Data, 2008-2013  137
Industry Trends And Developments   140
Industry Trends & Developments     140
Table: Funding Allocation For Elective Surgery By State, July 2013  143
Regulatory Development  151
Medical Device Regulations     151
Medical Device Pricing & Reimbursement   155
Competitive Landscape   157
Domestic Medical Device Production    157
Table: Medical Device Manufacturers By Type, 2005-2011   158
Table: Electromedical & Radiology Equipment Manufacturers By Type, Key Indicators, 2011   159
Table: Medical & Surgical Instrument Manufacturers By Type, Key Indicators, 2011  159
Table: Medical Supplies Manufacturers By Type, Key Indicators, 2011   161
Table: Medical Device Production By Type, 2007-2011 (BRL000)  162
Table: Medical Device Production By Type, 2007-2011 (US$000)  165
Domestic Medical Device Manufacturing    169
Table: Medical Device Industry Economic Data, 2005-2011 (US$mn)      169
National Medical Device Manufacturers     171
Table: Cremer Net Revenues, 2011 - June 2013 (BRLmn)    173
Multinational Medical Device Manufacturers  182
Multinational Market Activity   192
Table: Multinational Market Activity, 2013  192
Medical Device Market Access     195
Market Environment     195
Distribution     196
Mercosur     196
Import Duties & Taxes     197
Table: CET for Medical Devices as at 25th April 2012   197
Trade Associations      204
Table: ABIMED Members, 2013     204
Trade Fairs     207
Methodology     210
Table: Used HS Trade Codes, 2013     211
Table: Rearranged HS Trade Codes, 2013    213

  • Global Cystic Fibrosis Market Propelled by Technological Advancement
    With increasing prevalence of cystic fibrosis and its growing awareness among people, the global market for cystic fibrosis is expected to grow at a steady pace. Cystic fibrosis is a genetic condition where the lungs and digestive system becomes clogged with excess mucus. This condition is more common among Caucasian population than people of Asian [...]
  • Bright Prospects Ahead for the SONAR Systems and Technology Market
    With advancement of technology, the global SONAR systems and technology market is increasing at a rapid pace. SONAR which is an acronym for SOund Navigation And Ranging is a technique that uses sound propagation to navigate and communicate with objects on or under the surface of the water, such as other vessels. In 2014, the [...]
  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • To bring in Photography to the Real World Visual Supply Co Acquires Artifact Uprising
  • Visual Supply Co, VSCO has brought a Denver-based startup, Artifact Uprising, which is focused on bringing photographers’ work from the digital hubs on regular basis by modern creatives to the real world as prints and tangible books. Artifact Uprising is …

  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Peripheral Neuropathy (Sensory Neuropathy) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015', provides an overview of the Peripheral Neuropathy (Sensory Neuropathy)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along wit......
  • Polycystic Ovarian Syndrome – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Polycystic Ovarian Syndrome - Pipeline Review, H1 2015', provides an overview of the Polycystic Ovarian Syndrome's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press......
  • Dyslipidemia – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Dyslipidemia - Pipeline Review, H1 2015', provides an overview of the Dyslipidemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dyslipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players invo......
  • Growth Hormone Deficiency – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Growth Hormone Deficiency - Pipeline Review, H1 2015', provides an overview of the Growth Hormone Deficiency's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press relea......
  • Acute Heart Failure – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Acute Heart Failure - Pipeline Review, H1 2015', provides an overview of the Acute Heart Failure's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also revie......
  • Endometriosis – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Endometriosis - Pipeline Review, H1 2015', provides an overview of the Endometriosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players inv......
  • Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015', provides an overview of the Proliferative Vitreoretinopathy (PVR)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Proliferative Vitreoretinopathy (PVR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest update......
  • Diabetic Peripheral Neuropathy – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015', provides an overview of the Diabetic Peripheral Neuropathy's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ......
  • Kaposi’s Sarcoma – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Kaposi's Sarcoma - Pipeline Review, H1 2015', provides an overview of the Kaposi's Sarcoma's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs